What is TITANBIO.BO's gross margin?

Titan Biotech (TITANBIO.BO) has a gross margin of 39% and a net margin of 14%.

What is TITANBIO.BO's P/E ratio?

TITANBIO.BO's P/E ratio is 47.4 with ROE of 18%.

Where can I see TITANBIO.BO's full financials?

See Titan Biotech (TITANBIO.BO) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Titan Biotech (TITANBIO.BO) Financials — Revenue, Earnings, Cash Flow

₹383.10 ($3.98)

-8.40 (-2.15%)

BSE · Healthcare · Biotechnology · Tech Score Sell · Power 47 · ₹16.2B mcap · 13M float · 0.196% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

₹2B

Revenue

+31.8% YoY

₹299M

Net Income

+38.8% YoY

₹131M

Free Cash Flow

+247.1% YoY

39.5%

Gross Margin

17.2%

Op. Margin

13.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE17.8%

ROA15.4%

ROIC13.4%

Valuation

P/E47.4

P/B8.8

EV/EBITDA46.5

Leverage

Debt/Equity0.03

Current Ratio3.28

Interest Cov.39.1x

Quality Scores

Piotroski F5/9

Altman Z36.85

Beneish M-1.59